Dr Reddys Laboratories (RDY) Deferred Taxes (2009)

Dr Reddys Laboratories (RDY) posted quarterly Deferred Taxes of -$15.0 million for Q4 2009, down 225.0% on a QoQ basis from $12.0 million in Q3 2009.

Dr Reddys Laboratories (RDY) Deferred Taxes (2009) Analysis & Trends

Dr Reddys Laboratories (RDY) has reported Deferred Taxes for 1 consecutive years, with -$15.0 million the latest figure, recorded in Q4 2009.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -22.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 34.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 25.90 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -69.70 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -61.10 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Dr Reddys Laboratories 9.82 Bn 9.66 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2009 -15.00 Mn
Sep 30, 2009 12.00 Mn
Jun 30, 2009 15.00 Mn